BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2014
View Archived Issues
Phase II results on cediranib in advanced biliary tract cancer
Read More
Researchers identify novel polymorphism associated with the risk of miscarriage
Read More
Synthetic Biologics and Enterome Bioscience collaborate on microbiome research
Read More
FDA grants orphan drug status to Afinitor in DLBCL
Read More
Edison Pharmaceuticals obtains FDA orphan drug designation for Leigh syndrome candidate
Read More
Isis Pharmaceuticals earns milestone payment for start of phase I ISIS-AR-Rx study
Read More
BrainStorm Cell Therapeutics initiates preclinical studies of stem cell therapy in autism
Read More
Nymox Pharmaceutical reports new safety study data for NX-1207
Read More
Lilly reports topline results from phase III trial of ramucirumab
Read More
Amgen presents first-in-human results for AMG-780
Read More
High-affinity SV2A PET tracer [11C]UCB-J shows promise in animal models
Read More
VGX-100 shows promise as monotherapy or as combination with bevacizumab in first-in-human trial
Read More
X-Chem and Pfizer form multi-target collaboration
Read More
Beactica enters into drug discovery collaboration with Medivir
Read More
AstraZeneca inlicenses Synairgen's SNG-001
Read More
University of Pennsylvania researchers gain access to SomaLogic's SOMAscan proteomics platform
Read More
Tipelukast shows promise in pulmonary fibrosis model
Read More
Genomic Health reports topline results from independent validation study
Read More
Chinese company reports discovery of H+/K+-ATPase inhibitors
Read More
U.S. investigators patent new compounds for diabetes and obesity
Read More
Adelaide Research and Innovation synthesizes novel calpain inhibitors
Read More
Northwest Biotherapeutics reports data from phase I/II trial of DCVax-Direct
Read More
IRM and Novartis report synthesis of compounds for malaria
Read More
Bayer patents detail novel CDK9/CycT1 inhibitors
Read More
Phase III data: efficacy of fluticasone furoate/vilanterol improved by adding umeclidinium in COPD
Read More
Ruthigen to begin human trials of RUT-58-60 in the U.S.
Read More
FDA approves Gadavist as a contrast agent for the evaluation of breast cancer
Read More
